Almasi et al. found that in lung cancer tissues, the inhibition of TRPM2 could lead to G2/M arrest and apoptosis by increasing intracellular RNS and ROS levels and activating the JNK pathway (Almasi et al., 2019). Here, TRPM2 is linked to lung carcinoma.